BioCentury
ARTICLE | Company News

Chiron deal

November 15, 1993 8:00 AM UTC

CHIR and diagnostic partner Ortho Diagnostic Systems Inc. reached cross-licensing agreements covering HIV-1 and HIV-2 immunodiagnostic products with Pasteur Sanofi Diagnostics and Genetic Systems Corp., a subsidiary of Sanofi Diagnostics Pasteur Inc.

CHIR said the agreements, which provide worldwide rights under existing and future patents for the manufacture, use and sales of HIV-1 and HIV-2 immunodiagnostics, give the companies "a strong proprietary position" in the field of HIV diagnostics. The cross-license is based on the discovery of HIV at Institute Pasteur and CHIR's work in sequencing the HIV genome and in the development of recombinant/synthetic HIV proteins. ...